Target intelligence / Profile preview

Cysteinyl-tRNA synthetase 1 pseudogene 2 (CARS1P2)

Target
CARS1P2
Molecular classification
Other (Pseudogene)
01

Overview

Cysteinyl-tRNA synthetase 1 pseudogene 2 (CARS1P2) is a genetic element classified as a pseudogene and is not believed to encode a functional protein. It is named for its homology to the active gene cysteinyl-tRNA synthetase 1 (CARS1), which catalyzes the attachment of cysteine to its corresponding tRNA during protein synthesis, but CARS1P2 itself lacks coding potential and no biological, pathological, or therapeutic roles have been reported[1][5][6]. Context and supporting details: - CARS1P2 is distinct from CARS1 (also known as cysteinyl-tRNA synthetase 1), which is a functional enzyme involved in protein biosynthesis and associated with various human diseases[4][7]. - No evidence in the scientific or medical literature supports CARS1P2 as a therapeutic target, receptor, enzyme, or drug-interacting protein[1][5][6]. - Pseudogenes such as CARS1P2 do not generally produce functional proteins or have direct biological functions but may occasionally have regulatory roles; no such roles are documented for this locus[1][5][6]. - Relevant biomedical databases classify CARS1P2 strictly as a pseudogene, and no published studies link it to disease, drug interactions, or biomarker utility[1][5][6]. Summary: CARS1P2 is a noncoding pseudogene with no direct functional, therapeutic, or diagnostic relevance. It should not be considered a molecular target, and there are no known roles in health or disease. If you intended to inquire about the active enzyme cysteinyl-tRNA synthetase 1 (CARS1), please specify[4][7].

Other names
CARSP2cysteinyl-tRNA synthetase pseudogene 2CARS1P2

Beyond the preview

Go deeper on Cysteinyl-tRNA synthetase 1 pseudogene 2 (CARS1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteinyl-tRNA synthetase 1 pseudogene 2 (CARS1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call